Endocannabinoid system and stress and anxiety responses.
paper
Cited
Public
Unavailable
- Authors
- Viveros, M P; Marco, Eva M; File, Sandra E
- Year
- 2005
- Journal
- Pharmacology, biochemistry, and behavior
- PMID
- 15927244
- DOI
- 10.1016/j.pbb.2005.01.029
Cannabinoid agonists induce complex and often contradictory effects on anxiety in humans and experimental animals. The data from animal tests provide evidence of dose-dependent bidirectional modulation of anxiety by the cannabinoid system and the importance of environmental context. The mechanisms mediating the effects of cannabinoids on anxiety-related responses appear to involve CB1 and non-CB1 cannabinoid receptors. In addition, the CRH, GABA(A), cholecystokinin, opioid and serotonergic systems have also been implicated. Brain regions such as the amygdala, hippocampus and cortex, directly involved in the regulation of emotional behavior, contain high densities of CB1 receptors. Mutant mice lacking CB1 receptors show anxiogenic-like and depressive-like phenotypes in several tests, as well as profound alterations in their adrenocortical activity. Pharmacological blockade of CB1 receptors induces anxiety in rats, and inhibition of anandamide metabolism produces anxiolytic-like effects. Thus, the endocannabinoid system appears to play a pivotal role in the regulation of emotional states and may constitute a novel pharmacological target for anti-anxiety therapy.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Medial prefrontal cortical CB1Rs and astrocytes are involved in depression and the antidepressant effects of running exercise in male rats. | Huang DJ et al. | β | 2026 | β |
| Sex-specific association between low oral doses of cannabidiol (CBD) and plasma concentration of anandamide (AEA), N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) in healthy occasional cannabis users. | Abboud A et al. | β | 2026 | β |
| The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety. | Lyndon S | β | 2026 | β |
| Allosteric Modulation of Cannabinoid Type 1 Receptor by ZCZ011: Integration of In Vitro Pharmacology and Molecular Dynamics Simulation. | Yadav TC et al. | β | 2025 | β |
| Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy. | Pakkhesal S et al. | β | 2025 | β |
| Cannabinoid Receptor 1: The Neural Gatekeeper of Health and Disease. | Goyal A et al. | β | 2025 | β |
| CB<sub>1</sub> receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes. | Gao Q et al. | β | 2025 | β |
| Combination treatment with medium dose THC and CBD had no therapeutic effect in a transgenic mouse model for Alzheimer's disease but affected other domains including anxiety-related behaviours and object recognition memory. | Aumer B et al. | β | 2025 | β |
| Divergent outcomes of delta 9 - tetrahydrocannabinol (THC) in adolescence on mesocortical dopamine and cognitive development in male and female mice. | Capolicchio T et al. | β | 2025 | β |
| Effects of pharmacological inhibition of fatty acid amide hydrolase on corticosterone release: a systematic review of preclinical studies. | Pereira CF et al. | β | 2025 | β |
| Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress. | Dragon J et al. | β | 2025 | β |
| Fatty acid binding proteins and their involvement in anxiety and mood disorders. | Jones MJ et al. | β | 2025 | β |
| Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort. | Steeger CM et al. | β | 2025 | β |
| Longitudinal analysis of genetic and environmental interplay in human metabolic profiles and the implication for metabolic health. | Wang J et al. | β | 2025 | β |
| Medial Prefrontal Cortical CB1Rs and Astrocytes Are Involved in Depression and the Antidepressant Effects of Running Exercise | Tang Y et al. | β | 2025 | β |
| The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. | Rao JS et al. | β | 2025 | β |
| Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders. | Ricardi C et al. | β | 2024 | β |
| Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits. | Jha SK et al. | β | 2024 | β |
| Cannabinoid and Serotonergic Systems: Unraveling the Pathogenetic Mechanisms of Stress-Induced Analgesia. | Nocheva H et al. | β | 2024 | β |
| Different stressors uniquely affect the expression of endocannabinoid-metabolizing enzymes in the central ring ganglia of Lymnaea stagnalis. | Rivi V et al. | β | 2024 | β |
| Examination of the Effect of Dimethyl Trisulfide in Acute Stress Mouse Model with the Potential Involvement of the TRPA1 Ion Channel. | GΓΆntΓ©r K et al. | β | 2024 | β |
| Inhibition of fatty acid binding protein-5 in the basolateral amygdala induces anxiolytic effects and accelerates fear memory extinction. | Jones MJ et al. | β | 2024 | β |
| Long-term Effects of Cannabidiol and/or Fentanyl Exposure in Rats Submitted to Neonatal Pain. | RΓͺgo DSB et al. | β | 2024 | β |
| Sex-Specific Differences and the Role of Environmental Enrichment in the Expression of Hippocampal CB<sub>1</sub> Receptors following Chronic Unpredictable Stress. | Dandi E et al. | β | 2024 | β |
| Synbiotic supplementation ameliorates anxiety and myocardial ischaemia-reperfusion injury in hyperglycaemic rats by modulating gut microbiota. | Bulut EC et al. | β | 2024 | β |
| The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies. | Ayoub SM et al. | β | 2024 | β |
| Cannabis sativa-based oils against aluminum-induced neurotoxicity. | Alves C et al. | β | 2023 | β |
| Effects of Ξ<sup>9</sup>-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis. | Iglesias LP et al. | β | 2023 | β |
| Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review. | Singh K et al. | β | 2023 | β |
| Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders. | Frankowska M et al. | β | 2023 | β |
| Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls. | Spohrs J et al. | β | 2023 | β |
| Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis. | RamΓrez S et al. | β | 2022 | β |
| Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer's disease symptoms: a case report. | Ruver-Martins AC et al. | β | 2022 | β |
| Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance. | Narayan AJ et al. | β | 2022 | β |
| Emerging trends in point-of-care sensors for illicit drugs analysis. | Dagar M et al. | β | 2022 | β |
| Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review. | Hen-Shoval D et al. | β | 2022 | β |
| Exploration of Multiverse Activities of Endocannabinoids in Biological Systems. | Behl T et al. | β | 2022 | β |
| In the Swim of Cannabis: Developmental Toxicity and Metabolomic Pathway Alterations of Zebrafish Larvae Exposed to THC for the Assessment of Its Potential Environmental and Human Health Impact. | Chatzimitakos T et al. | β | 2022 | β |
| Mice lacking proSAAS display alterations in emotion, consummatory behavior and circadian entrainment. | Aryal DK et al. | β | 2022 | β |
| The cannabinoid receptor-1 gene interacts with stressful life events to increase the risk for problematic alcohol use. | Bornscheuer L et al. | β | 2022 | β |
| The endocannabinoid system and drug-associated contextual memories. | Asth L et al. | β | 2022 | β |
| The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder. | Bonn-Miller MO et al. | β | 2022 | β |
| Translational models of cannabinoid vapor exposure in laboratory animals. | Moore CF et al. | β | 2022 | β |
| A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction. | Peters KZ et al. | β | 2021 | β |
| A review of the effects of acute and chronic cannabinoid exposure on the stress response. | Glodosky NC et al. | β | 2021 | β |
| CB<sub>1</sub> allosteric modulators and their therapeutic potential in CNS disorders. | Mielnik CA et al. | β | 2021 | β |
| Chronic Inhibition of FAAH Reduces Depressive-Like Behavior and Improves Dentate Gyrus Proliferation after Chronic Unpredictable Stress Exposure. | Tejeda-MartΓnez AR et al. | β | 2021 | β |
| Distribution of the Cannabinoid Receptor Type 1 in the Brain of the Genetically Audiogenic Seizure-Prone Hamster GASH/Sal. | Fuerte-HortigΓ³n A et al. | β | 2021 | β |
| Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping. | Goldstein Ferber S et al. | β | 2021 | β |
| Endocannabinoids and Precision Medicine for Mood Disorders and Suicide. | Pinna G | β | 2021 | β |
| Further evidence of anxiety- and depression-like behavior for total genetic ablation of cannabinoid receptor type 1. | Soriano D et al. | β | 2021 | β |
| The interaction effect of sleep deprivation and cannabinoid type 1 receptor in the CA1 hippocampal region on passive avoidance memory, depressive-like behavior and locomotor activity in rats. | Rezaie M et al. | β | 2021 | β |
| Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARΞ³ in Developmental Toxicities Following Exposure to Ξ9-Tetrahydrocannabinol and Cannabidiol. | Pandelides Z et al. | β | 2021 | β |
| Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms. | DeVuono MV et al. | β | 2020 | β |
| Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study. | Rabinak CA et al. | β | 2020 | β |
| Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases. | Haspula D et al. | β | 2020 | β |
| Cannabinoids and their therapeutic applications in mental disordersβ©. | Scherma M et al. | β | 2020 | β |
| Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid. | Chousidis I et al. | β | 2020 | β |
| Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. | Sharpe L et al. | β | 2020 | β |
| Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice. | Bouter Y et al. | β | 2020 | β |
| Chronic Treatment with 50βmg/kg Cannabidiol Improves Cognition and Moderately Reduces AΞ²40 Levels in 12-Month-Old Male AΞ²PPswe/PS1ΞE9 Transgenic Mice. | Watt G et al. | β | 2020 | β |
| Effects of cannabis exposure in the prenatal and adolescent periods: Preclinical and clinical studies in both sexes. | Tirado-MuΓ±oz J et al. | β | 2020 | β |
| Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. | Vimalanathan A et al. | β | 2020 | β |
| Endocannabinoid System Components as Potential Biomarkers in Psychiatry. | Navarrete F et al. | β | 2020 | β |
| Nausea-Induced Conditioned Gaping Reactions in Rats Produced by High-Dose Synthetic Cannabinoid, JWH-018. | DeVuono MV et al. | β | 2020 | β |
| Possible therapeutic applications of cannabis in the neuropsychopharmacology field. | FernΓ‘ndez-Ruiz J et al. | β | 2020 | β |
| The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review. | Hindocha C et al. | β | 2020 | β |
| The role of catecholamines in modulating responses to stress: Sex-specific patterns, implications, and therapeutic potential for post-traumatic stress disorder and opiate withdrawal. | Ross JA et al. | β | 2020 | β |
| A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis. | Loflin MJE et al. | β | 2019 | β |
| Awareness of Emotional Expressions in Cannabis Users: An Event-Related Potential Study. | Torrence RD et al. | β | 2019 | β |
| Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology. | Rodrigues RS et al. | β | 2019 | β |
| Cannabinoid CB<sub>1</sub> receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT<sub>1A</sub> receptor activation. | Batista LA et al. | β | 2019 | β |
| Cannabinoids, interoception, and anxiety. | Andrade AK et al. | β | 2019 | β |
| Chronic nicotine exposure attenuates the effects of Ξ<sup>9</sup> -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats. | Manwell LA et al. | β | 2019 | β |
| Ethanol and cannabinoids interact to alter behavior in a zebrafish fetal alcohol spectrum disorder model. | Boa-Amponsem O et al. | β | 2019 | β |
| Impact of FAAH genetic variation on fronto-amygdala function during emotional processing. | GΓ€rtner A et al. | β | 2019 | β |
| Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats. | Pourrahimi AM et al. | β | 2019 | β |
| Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system. | Khakpai F et al. | β | 2019 | β |
| Synthetic cannabinoid use disorder: an update for general psychiatrists. | Grigg J et al. | β | 2019 | β |
| Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature. | Tartaglia N et al. | β | 2019 | β |
| Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae. | Achenbach JC et al. | β | 2018 | β |
| Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework. | Greenwald MK | β | 2018 | β |
| Bidirectional influence of amygdala Ξ²<sub>1</sub>-adrenoceptors blockade on cannabinoid signaling in contextual and auditory fear memory. | Nasehi M et al. | β | 2018 | β |
| Biomarkers for PTSD at the Interface of the Endocannabinoid and Neurosteroid Axis. | Pinna G | β | 2018 | β |
| Cancer and Complementary Therapies: Current Trends in Survivors' Interest and Use. | Qureshi M et al. | β | 2018 | β |
| Cannabinoids in depressive disorders. | Poleszak E et al. | β | 2018 | β |
| Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome. | Vigli D et al. | β | 2018 | β |
| Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD. | Fidelman S et al. | β | 2018 | β |
| Emerging Therapeutic Role of PPAR-Ξ± in Cognition and Emotions. | Nisbett KE et al. | β | 2018 | β |
| Highway to hell or magic smoke? The dose-dependence of Ξ<sup>9</sup>-THC in place conditioning paradigms. | Kubilius RA et al. | β | 2018 | β |
| Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice. | Pekala K et al. | β | 2018 | β |
| Investigating the mediational role of negative urgency in the anxiety sensitivity pathway to cannabis problems and dependence symptoms among postsecondary students. | Keough MT et al. | β | 2018 | β |
| New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. | Scherma M et al. | β | 2018 | β |
| Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress. | Surkin PN et al. | β | 2018 | β |
| Residual effects of cannabis use on attentional bias towards fearful faces. | Torrence RD et al. | β | 2018 | β |
| The association between adolescent cannabis use and anxiety: A parallel process analysis. | Duperrouzel J et al. | β | 2018 | β |
| The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity. | Struik D et al. | β | 2018 | β |
| Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors. | Bhattacharyya S et al. | β | 2017 | β |
| Cannabinoids as therapeutic for PTSD. | Loflin MJ et al. | β | 2017 | β |
| Cannabinoid signaling in health and disease. | Lu Y et al. | β | 2017 | β |
| Cannabis and development of dual diagnoses: A literature review. | Hanna RC et al. | β | 2017 | β |
| Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response. | R Wyrofsky R et al. | β | 2017 | β |
| Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion. | Reyes BAS et al. | β | 2017 | β |
| Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. | Childs E et al. | β | 2017 | β |
| Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack. | Batista LA et al. | β | 2017 | β |
| Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex. | MacDowell KS et al. | β | 2017 | β |
| Endocannabinoid mechanism in amphetamine-type stimulant use disorders: A short review. | Su H et al. | β | 2017 | β |
| Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats. | Faraji N et al. | β | 2017 | β |
| N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus. | Gobira PH et al. | β | 2017 | β |
| Role of Leptin and Orexin-A Within the Suprachiasmatic Nucleus on Anxiety-Like Behaviors in Hamsters. | AlΓ² R et al. | β | 2017 | β |
| Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model. | Oltrabella F et al. | β | 2017 | β |
| Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. | Marco EM et al. | β | 2017 | β |
| The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event. | Shoshan N et al. | β | 2017 | β |
| The Endocannabinoid System and Anxiety. | Lisboa SF et al. | β | 2017 | β |
| Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J mice. | Cannizzaro C et al. | β | 2016 | β |
| Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats. | Rock EM et al. | β | 2016 | β |
| Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal-Accumbens Plasticity After Stress. | Segev A et al. | β | 2016 | β |
| Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. | Mizrachi Zer-Aviv T et al. | β | 2016 | β |
| Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. | Alteba S et al. | β | 2016 | β |
| Cannabis-induced Moto-Cognitive Dysfunction in Wistar Rats: Ameliorative Efficacy of Nigella Sativa. | Imam A et al. | β | 2016 | β |
| CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice. | Kruk-Slomka M et al. | β | 2016 | β |
| Clinical applications of hallucinogens: A review. | Garcia-Romeu A et al. | β | 2016 | β |
| Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana. | Cermak TL | β | 2016 | β |
| Concentration, population, and context-dependent effects of AM251 in zebrafish. | Tran S et al. | β | 2016 | β |
| Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands. | Kruk-Slomka M et al. | β | 2016 | β |
| Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats. | Khodayar E et al. | β | 2016 | β |
| Facilitatory effect of AM281 on recognition memory in rats. | Bialuk I et al. | β | 2016 | β |
| Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. | Breuer A et al. | β | 2016 | β |
| From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. | Ligresti A et al. | β | 2016 | β |
| Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains. | Jennings EM et al. | β | 2016 | β |
| Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans. | Cedernaes J et al. | β | 2016 | β |
| Targeting the endocannabinoid system to treat anxiety-related disorders. | Korem N et al. | β | 2016 | β |
| The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats. | Aliczki M et al. | β | 2016 | β |
| The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders. | Hassanzadeh P et al. | β | 2016 | β |
| The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. | Berardi A et al. | β | 2016 | β |
| Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system. | Kruk-Slomka M et al. | β | 2015 | β |
| Anxiogenic-like effects induced by hemopressin in rats. | FogaΓ§a MV et al. | β | 2015 | β |
| Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour. | RodrΓguez-Manzo G et al. | β | 2015 | β |
| Cannabidiol as a Potential Treatment for Anxiety Disorders. | Blessing EM et al. | β | 2015 | β |
| Cannabis and psychopathology: The meandering journey of the last decade. | Ghosh A et al. | β | 2015 | β |
| CB1 receptors modulate affective behaviour induced by neuropathic pain. | RΓ‘cz I et al. | β | 2015 | β |
| Drug effects on responses to emotional facial expressions: recent findings. | Miller MA et al. | β | 2015 | β |
| Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial. | Andries A et al. | β | 2015 | β |
| Effects of CB1 receptor agonism and antagonism on behavioral fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats. | Simone JJ et al. | β | 2015 | β |
| Elucidating cannabinoid biology in zebrafish (Danio rerio). | Krug RG et al. | β | 2015 | β |
| Endocannabinoids and Mental Disorders. | Rubino T et al. | β | 2015 | β |
| Endocannabinoids and striatal function: implications for addiction-related behaviours. | Moreira FA et al. | β | 2015 | β |
| Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System. | Lisboa SF et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Novel investigational therapeutics for panic disorder. | Perna G et al. | β | 2015 | β |
| Part II: Strain- and sex-specific effects of adolescent exposure to THC on adult brain and behaviour: Variants of learning, anxiety and volumetric estimates. | Keeley RJ et al. | β | 2015 | β |
| Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety. | Marco EM et al. | β | 2015 | β |
| Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses. | Batista LA et al. | β | 2015 | β |
| Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze. | Komaki A et al. | β | 2015 | β |
| The dark side of emotion: the addiction perspective. | Koob GF | β | 2015 | β |
| The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA. | Kangarlu-Haghighi K et al. | β | 2015 | β |
| The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors. | Batista PA et al. | β | 2015 | β |
| Animals with a schizophrenia-like phenotype are differentially sensitive to the motivational effects of cannabinoid agonists in conditioned place preference. | Gallo A et al. | β | 2014 | β |
| Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli. | Laricchiuta D et al. | β | 2014 | β |
| Blockade of CB1 receptors prevents retention of extinction but does not increase low preincubated conditioned fear in the fear incubation procedure. | Pickens CL et al. | β | 2014 | β |
| Cannabinoid modulation of amygdala subregion functional connectivity to social signals of threat. | Gorka SM et al. | β | 2014 | β |
| Cannabinoid modulation of fear extinction brain circuits: a novel target to advance anxiety treatment. | Rabinak CA et al. | β | 2014 | β |
| Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray. | Lisboa SF et al. | β | 2014 | β |
| Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. | Segev A et al. | β | 2014 | β |
| Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice. | Terzian AL et al. | β | 2014 | β |
| Cannabis use among treatment-seeking smokers: motives and the moderating effects of anxiety sensitivity. | Norberg MM et al. | β | 2014 | β |
| Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats. | Stopponi S et al. | β | 2014 | β |
| Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice. | Chegini HR et al. | β | 2014 | β |
| Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain. | Almeida V et al. | β | 2014 | β |
| Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. | Levin R et al. | β | 2014 | β |
| Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice. | Haller J et al. | β | 2014 | β |
| Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster. | AlΓ² R et al. | β | 2014 | β |
| Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. | Shonesy BC et al. | β | 2014 | β |
| Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli. | Rea K et al. | β | 2014 | β |
| Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs. | Batista LA et al. | β | 2014 | β |
| On deep history and pyschotropy. | Campbell B | β | 2014 | β |
| Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report. | Bergamaschi MM et al. | β | 2014 | β |
| Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats. | Lopez-Rodriguez AB et al. | β | 2014 | β |
| The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze. | Kochenborger L et al. | β | 2014 | β |
| Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism. | Pascual AC et al. | β | 2013 | β |
| Cannabinoid CBβ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations. | HΓ€ring M et al. | β | 2013 | β |
| Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. | Spano MS et al. | β | 2013 | β |
| Dissociation of the pharmacological effects of THC by mTOR blockade. | Puighermanal E et al. | β | 2013 | β |
| Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. | O'Brien LD et al. | β | 2013 | β |
| Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats. | Vilela LR et al. | β | 2013 | β |
| Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze. | Gobira PH et al. | β | 2013 | β |
| Emotional, endocrine and brain anandamide response to social challenge in infant male rats. | Marco EM et al. | β | 2013 | β |
| Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats. | MΓ©ndez-DΓaz M et al. | β | 2013 | β |
| Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential. | Hassanzadeh P et al. | β | 2013 | β |
| Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat. | Zavitsanou K et al. | β | 2013 | β |
| Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists. | Kirilly E et al. | β | 2013 | β |
| Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms. | Campos AC et al. | β | 2013 | β |
| Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment. | Bailey CR et al. | β | 2013 | β |
| Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. | Hayase T | β | 2013 | β |
| Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. | Trezza V et al. | β | 2012 | β |
| Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Luchicchi A et al. | β | 2012 | β |
| Antidepressant-like effects of ΞβΉ-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression. | Elbatsh MM et al. | β | 2012 | β |
| A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity. | Conzelmann A et al. | β | 2012 | β |
| Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. | Rey AA et al. | β | 2012 | β |
| Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. | Campos AC et al. | β | 2012 | β |
| Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders. | Carvalho AF et al. | β | 2012 | β |
| Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. | Ganon-Elazar E et al. | β | 2012 | β |
| Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? | Moreira FA et al. | β | 2012 | β |
| CB1 receptor antagonists: new discoveries leading to new perspectives. | Kirilly E et al. | β | 2012 | β |
| Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor. | Umathe SN et al. | β | 2012 | β |
| Endocannabinoid System and TRPV1 Receptors in the Dorsal Hippocampus of the Rats Modulate Anxiety-like Behaviors. | Hakimizadeh E et al. | β | 2012 | β |
| Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it. | Riebe CJ et al. | β | 2012 | β |
| Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. | Dubreucq S et al. | β | 2012 | β |
| Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. | LΓ³pez-Gallardo M et al. | β | 2012 | β |
| Neuroanatomical substrates involved in cannabinoid modulation of defensive responses. | Moreira FA et al. | β | 2012 | β |
| Neuronal populations mediating the effects of endocannabinoids on stress and emotionality. | HΓ€ring M et al. | β | 2012 | β |
| Presynaptic Ξ±β-adrenoceptors control the inhibitory action of presynaptic CBβ cannabinoid receptors on prefrontocortical norepinephrine release in the rat. | Richter H et al. | β | 2012 | β |
| Psychobiological responses to unpleasant emotions in cannabis users. | Somaini L et al. | β | 2012 | β |
| Testing the effects of Ξ9-THC and D-cycloserine on extinction of conditioned fear in humans. | Klumpers F et al. | β | 2012 | β |
| The CBβ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin. | Hassanzadeh P et al. | β | 2012 | β |
| The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. | FogaΓ§a MV et al. | β | 2012 | β |
| The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential. | Finn DP et al. | β | 2012 | β |
| The endocannabinoid system in anxiety, fear memory and habituation. | Ruehle S et al. | β | 2012 | β |
| The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. | Viveros MP et al. | β | 2012 | β |
| The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. | Campolongo P et al. | β | 2012 | β |
| Toward a mechanistic understanding of how variability in neurobiology shapes individual differences in behavior. | Bogdan R et al. | β | 2012 | β |
| AAV-Mediated Overexpression of the CB1 Receptor in the mPFC of Adult Rats Alters Cognitive Flexibility, Social Behavior, and Emotional Reactivity. | Klugmann M et al. | β | 2011 | β |
| Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids-Cannabinoids and Acute Stress Modulate GABA Release. | Delgado A et al. | β | 2011 | β |
| Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems. | Zarrindast MR et al. | β | 2011 | β |
| Associations of social phobia and general anxiety with alcohol and drug use in a community sample of adolescents. | FrΓΆjd S et al. | β | 2011 | β |
| Cannabinoid CB1 and Dopamine D1 Receptors Partnership in the Modulation of Emotional Neural Processing. | Akirav I et al. | β | 2011 | β |
| Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. | Klugmann M et al. | β | 2011 | β |
| Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. | HΓ€ring M et al. | β | 2011 | β |
| Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. | Campolongo P et al. | β | 2011 | β |
| Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress. | Granjeiro EM et al. | β | 2011 | β |
| Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. | Serrano A et al. | β | 2011 | β |
| Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. | Sidhpura N et al. | β | 2011 | β |
| Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat. | Dean C | β | 2011 | β |
| Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. | Marco EM et al. | β | 2011 | β |
| Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. | Viveros MP et al. | β | 2011 | β |
| Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal. | Mannucci C et al. | β | 2011 | β |
| Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. | Umathe SN et al. | β | 2011 | β |
| Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists. | Hassanzadeh P et al. | β | 2011 | β |
| Medicinal plants and dementia therapy: herbal hopes for brain aging? | Perry E et al. | β | 2011 | β |
| Modulation of cortisol levels, endocannabinoid receptor 1A, proopiomelanocortin and thyroid hormone receptor alpha mRNA expressions by probiotics during sole (Solea solea) larval development. | Palermo FA et al. | β | 2011 | β |
| Modulation of the serotonin system by endocannabinoid signaling. | Haj-Dahmane S et al. | β | 2011 | β |
| Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. | Crippa JA et al. | β | 2011 | β |
| Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. | Sumislawski JJ et al. | β | 2011 | β |
| Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. | Kamprath K et al. | β | 2011 | β |
| The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs. | Hassanzadeh P et al. | β | 2011 | β |
| The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. | Viveros MP et al. | β | 2011 | β |
| The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. | Akirav I | β | 2011 | β |
| The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin. | Hassanzadeh P et al. | β | 2011 | β |
| The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. | Boucher AA et al. | β | 2011 | β |
| Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. | Herrera-SolΓs A et al. | β | 2010 | β |
| Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. | Cornelius JR et al. | β | 2010 | β |
| Anandamide prior to sensitization increases cell-mediated immunity in mice. | Ribeiro A et al. | β | 2010 | β |
| Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. | Zanelati TV et al. | β | 2010 | β |
| Cannabinoid-hormone interactions in the regulation of motivational processes. | LΓ³pez HH | β | 2010 | β |
| Cannabinoids and anxiety. | Moreira FA et al. | β | 2010 | β |
| Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety. | Arnold JC et al. | β | 2010 | β |
| Cannabinoids modulate cell survival in embryoid bodies. | Nones J et al. | β | 2010 | β |
| Chronic adolescent exposure to Ξ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. | O'Tuathaigh CM et al. | β | 2010 | β |
| Contribution of limbic norepinephrine to cannabinoid-induced aversion. | Carvalho AF et al. | β | 2010 | β |
| Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis. | AlΓ©n F et al. | β | 2010 | β |
| Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress. | Fokos S et al. | β | 2010 | β |
| Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference. | Powers MS et al. | β | 2010 | β |
| Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. | Finn DP | β | 2010 | β |
| Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. | Campos AC et al. | β | 2010 | β |
| Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. | Lemos JI et al. | β | 2010 | β |
| The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines. | GarcΓa-GutiΓ©rrez MS et al. | β | 2010 | β |
| The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. | Jenny M et al. | β | 2010 | β |
| Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. | RodrΓguez-Gaztelumendi A et al. | β | 2009 | β |
| Antiaversive effects of cannabinoids: is the periaqueductal gray involved? | Moreira FA et al. | β | 2009 | β |
| Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. | Aguiar DC et al. | β | 2009 | β |
| Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. | Wegener N et al. | β | 2009 | β |
| Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. | Ganon-Elazar E et al. | β | 2009 | β |
| Cannabis and anxiety: a critical review of the evidence. | Crippa JA et al. | β | 2009 | β |
| Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. | Moreira FA et al. | β | 2009 | β |
| Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: altered responses to cannabinoid exposure. | Marco EM et al. | β | 2009 | β |
| Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. | Reich CG et al. | β | 2009 | β |
| Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. | Fusar-Poli P et al. | β | 2009 | β |
| Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. | Hariri AR et al. | β | 2009 | β |
| Dose-response effects of systemic anandamide administration in mice sequentially submitted to the open field and elevated plus-maze tests. | Ribeiro A et al. | β | 2009 | β |
| Endocannabinoid-mediated control of synaptic transmission. | Kano M et al. | β | 2009 | β |
| Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors. | Umathe SN et al. | β | 2009 | β |
| Endocannabinoid system and fear conditioning. | Resstel LB et al. | β | 2009 | β |
| Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. | Campos AC et al. | β | 2009 | β |
| Improving antidepressant drugs: update on recently patented compounds. | Rozas I | β | 2009 | β |
| Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. | Haller J et al. | β | 2009 | β |
| Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. | Thiemann G et al. | β | 2009 | β |
| Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis. | McLaughlin RJ et al. | β | 2009 | β |
| Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography. | Thomas A et al. | β | 2009 | β |
| Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. | Patel S et al. | β | 2009 | β |
| Subjective effects of cannabis before the first psychotic episode. | Peters BD et al. | β | 2009 | β |
| The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. | Morrison PD et al. | β | 2009 | β |
| The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. | Gaetani S et al. | β | 2009 | β |
| The endocannabinoid system as a target for the treatment of cannabis dependence. | Clapper JR et al. | β | 2009 | β |
| The neurobiology of individual differences in complex behavioral traits. | Hariri AR | β | 2009 | β |
| Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. | Lisboa SF et al. | β | 2008 | β |
| Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. | Quinn HR et al. | β | 2008 | β |
| Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. | Zarrindast MR et al. | β | 2008 | β |
| Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. | Phan KL et al. | β | 2008 | β |
| Cannabis and psychiatric disorders: it is not only addiction. | Leweke FM et al. | β | 2008 | β |
| Cat odour-induced anxiety--a study of the involvement of the endocannabinoid system. | SΓΌtt S et al. | β | 2008 | β |
| CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. | Rubino T et al. | β | 2008 | β |
| Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. | Steiner MA et al. | β | 2008 | β |
| Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia. | Suplita RL et al. | β | 2008 | β |
| Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. | Reich CG et al. | β | 2008 | β |
| Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. | Bitencourt RM et al. | β | 2008 | β |
| Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. | Steiner MA et al. | β | 2008 | β |
| Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. | Naderi N et al. | β | 2008 | β |
| Neurobiological mechanisms of cannabinoid addiction. | Fattore L et al. | β | 2008 | β |
| Neurobiology of addiction. An integrative review. | Goodman A | β | 2008 | β |
| [Neuropsychopharmacology of delta-9-tetrahydrocannabinol]. | Costentin J | β | 2008 | β |
| Partial cloning of CB1 cDNA and CB1 mRNA changes in stress responses in the Solea solea. | Palermo FA et al. | β | 2008 | β |
| Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats. | Newsom RJ et al. | β | 2008 | β |
| Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. | Moreira FA et al. | β | 2008 | β |
| The endocannabinoid system: emotion, learning and addiction. | Moreira FA et al. | β | 2008 | β |
| The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. | Scherma M et al. | β | 2008 | β |
| 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. | Braida D et al. | β | 2007 | β |
| Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus. | MaΔkowiak M et al. | β | 2007 | β |
| Anandamide: an update. | Smita K et al. | β | 2007 | β |
| An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives. | Fattore L et al. | β | 2007 | β |
| Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. | Moreira FA et al. | β | 2007 | β |
| A possible role for the endocannabinoid system in the neurobiology of depression. | Serra G et al. | β | 2007 | β |
| Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. | Bambico FR et al. | β | 2007 | β |
| Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats. | Rubino T et al. | β | 2007 | β |
| Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats. | Llorente R et al. | β | 2007 | β |
| Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats. | JΓ€rbe TU et al. | β | 2007 | β |
| Endocannabinoid system and synaptic plasticity: implications for emotional responses. | Viveros MP et al. | β | 2007 | β |
| Endocannabinoid system involvement in brain reward processes related to drug abuse. | Solinas M et al. | β | 2007 | β |
| Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. | Mangieri RA et al. | β | 2007 | β |
| Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats. | Marco EM et al. | β | 2007 | β |
| Estrogen recruits the endocannabinoid system to modulate emotionality. | Hill MN et al. | β | 2007 | β |
| Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. | Naidu PS et al. | β | 2007 | β |
| Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. | Boucher AA et al. | β | 2007 | β |
| Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2. | Pandolfo P et al. | β | 2007 | β |
| Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. | Marsch R et al. | β | 2007 | β |
| Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. | Roohbakhsh A et al. | β | 2007 | β |
| Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior. | GonzΓ‘lez-Cuevas G et al. | β | 2007 | β |
| The endocannabinoid system and extinction learning. | Lutz B | β | 2007 | β |
| The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. | LafenΓͺtre P et al. | β | 2007 | β |
| The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions. | Viveros MP et al. | β | 2007 | β |
| Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats. | Marco EM et al. | β | 2006 | β |
| Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. | Moreira FA et al. | β | 2006 | β |
| Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. | Kamprath K et al. | β | 2006 | β |
| Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. | Muntoni AL et al. | β | 2006 | β |
| Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. | Resstel LB et al. | β | 2006 | β |
| Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. | Vlachou S et al. | β | 2006 | β |
| Experimental models of stress. | Patchev VK et al. | β | 2006 | β |
| Genetics of suicide. | Bondy B et al. | β | 2006 | β |
| Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure. | Hill MN et al. | β | 2006 | β |
| New approaches to antidepressant drug discovery: beyond monoamines. | Berton O et al. | β | 2006 | β |
| Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. | Patel S et al. | β | 2006 | β |
| Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats. | Mendiguren A et al. | β | 2006 | β |
| The endocannabinoid system as an emerging target of pharmacotherapy. | Pacher P et al. | β | 2006 | β |
| Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. | Vandevoorde S et al. | β | 2005 | β |